Opening
Elizabeth J. Linder
Moderator
Fabio Cavalli
Chief Philanthropy Architect of Lifestyle Week
Keeping the community anti-inflammaged has now become a social responsibility. Fabio explains how he created the most compelling anti-inflammaging company of the century, by acting as the linchpin in driving the world’s necessary transition to societal health promotion, with the ultimate goal of making the world’s population happier and healthier.
Low-grade chronic inflammation (LGCI)
Iñigo San Millan
Head of Training staff at UAE Team Emirates
Inflammation related to sport.
Jeroen Swart
MBChB, MPhil (SEM), PhD, Head of Medical staff UAE Team Emirates
Inflammation related to sport.
Paolo Colombani
CSO & co-founder of A—I Company, Dr. sc. nat. ETH Zurich
Origin and introduction to low-grade chronic inflammation.
Sport
Mauro Gianetti
UAE Team Emirates Principal and CEO
Keeping our staff healthy as our ultimate goal – an improved lifestyle not just for athletes, but for all of our staff.
Jeroen Swart
Head medical staff UAE Team Emirates
Improving lifestyle and benefits for underlying conditions: diabetes, hypertension and obesity.
Iñigo San Millan
Head of Training staff at UAE Team Emirates
Monitoring LGCI in professional sports and recommendations to recreational athletes.
Yousif Mirza
UAE Team Emirates athlete
Importance of a healthy lifestyle to succeed as an athlete.
Kellie Pritchard-Peschek
Chief Community Officer of AI-Company, PhD (Exercise Science)
How low grade chronic inflammation impacts genders differently.
Nutrition / Medicine / Science
Heinz Beck
Three-Michelin-starred chef, Scientific Director Campus University Principe of Naples
How to eat and mix the right ingredients to stay healthy and improve your lifestyle in order to prevent LCGI.
Giovanni De Gaetano
Head of Department of Epidemiology and Prevention
The impact of Mediterranean diet and the Moli-sani study related to LCGI.
Maria B. Donati
Medical doctor, Philosophy Doctor
The impact of Mediterranean diet and the Moli-sani study related to LCGI.
Vincenzo Summa
Professor of Medicinal Chemistry, Department Pharmacy, School of Medicine and Surgery, University of Naples Federico II
LCGI in relation to dysmetabolism and netutraceuticals evolution.
Medicine and Diseases
Esteban Pombo-Villar
PhD CChem FRSC, CEO
Drug research for LGCI and relation between LGCI and cancer.
Linda Friedland
International health professional, medical doctor and corporate advisor
Inflammaging: role of LCGI on aging.
Andreas Wallnöfer
General Partner at BioMedPartners, Switzerland, and board member of several European biotech companies
Covid 19 and low-grade chronic inflammation (LGCI).
Tariq Mughal
MD FRCP FACP FRCPath, Clinical Professor of Hematological Oncology at the Tufts University Medical School, Boston, MA, USA and at the University of Buckingham Medical School, Buckingham, UK
LGCI and cancer: How LGCI can lead to some of the most aggressive forms of blood cancer.
Pietro Formisano
MD, PhD, Full Professor of Clinical Pathology, Department of Translational Medicine, ederico II University of Naples
Low-grade chronic inflammation (LGCI) and obesity.
Finance
Patrick Casparis
Founder & Director of Presidio Advisors Limited
Importance of individuals’ lifestyle within global healthcare sector.
Legal / Privacy
Patrick Storchenegger
Owner and managing partner of PST Legal AG
Blockchain technology applied to LGCI.
Raphael Baumann
Rechtsanwalt und Notar, Attorney at Law and Notary Public
Privacy and legal aspects.
Hans-Lothar Arth
European and German Patent Attorney and European Trademark and Design Attorney​
Intellectual property freedom within relations between CLGI and IP on lifestyle.
Technology
Gianpaolo Turri
Engineer, Scientist, CEO, Customer-Centricity and Total-Innovation™ advocate
Innovation in wellness and health-tech: the coolest techs, the near future innovation and the power of the mind.
Katia Walsh
Senior Vice President and Chief Strategy and Artificial Intelligence Officer at Levi Strauss & Co
Driving people’s behaviour to change their lifestyle and fight LGCI, improve quality of life and avoid premature ageing.
Simone Belia
CTO of A—I Company
Driving people’s behaviour to change their lifestyle and fight LGCI, improve quality of life and avoid premature ageing.
Francesco Cavalli
Co-Founder & Chief Visionary Officer at A—I Company
A—I Company: the first company to fight low-grade chronic inflammation. An anti-inflammaging ecosystem powered by a digital platform which gives you the tools to strengthen the immune system, prevent diseases and premature ageing, as well as help to contrast Covid-19.
Environment
Andreas Kipar
Landscape architect
From Adaptive Design to Digital Landscape, digital culture to promote environmental awareness and encourage reconnection with nature.